Atlas Trials

Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer.

Clinical trial NCT05425550 · TERMINATED

Trial details

NCT number
NCT05425550
Sponsor
Palleos Healthcare GmbH
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2022-08-29
Primary completion
2025-06-05
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.